Catalophore based drug design, repurposing and large-scale virtual screenings for novel therapeutics and better enzymes.
Innophore GmbH, an innovative Austrian company, revolutionizes protein research by using and linking big data with structural biology approaches. Innophore uses bioinformatics methods in combination with artificial intelligence (AI) to search structural databases of proteins based on annotated three-dimensional point clouds called “catalophores” (i.e., carriers of catalytic function). The team consisting of biochemists, physicists, structural biologists, and developers offers long-standing expertise in the research and development of structural biology software, new in-silico structural analyses, and customized application tools. Innophore’s patented CatalophoreTM technology was launched two years ago and is already successfully used by customers worldwide.